RE: Re-rate coming/ Price target19 Sep 2020 23:59
Hey SK, Similar view to you...£2 next 10 days, £2.50-£3.00 by mid-Oct. Doubt a scramble end of Oct as much of value will be in the share price by then, no point jumping in on the 29th Oct as nothing to be gained then unless you think Accustem is undervalued, (but not sure how you would be able to draw that conclusion).
Does feel manipulated though at the moment, (was good to see those Nasdaq volumes, will watch those this week) which I take as a compliment to TILS and is just down to when it is let go...
If we take GDR, (not invested there, steer clear of Covid due to difficulty of mid-term valuation), from £0.90 it's jumped to £1.50 in a week on back of no news - granted testing is more current so sentiment has changed but news was pending for weeks, so think it's been mm managed...maybe I'm too cynical...
Back to TILS...Shareholder approval a formality given the 6-7 key shareholders will already be onboard. So don't see that as the key date, think that will be when the IPO docs are pulled together and assume they will be available to ii's before we get to pick at the bones, hence would rather be in now. Too unpredictable as to when it will rise, but does feel as if momentum building again.
Only risk factor I see is proving the value of the product, i.e. does it have independently verified 45% supremacy of the product...I would have thought that would have had some sort of peer review off the back of the ASCO socialisation so hoping not an issue...
...and as an aside...I also expect at some point the US will react after LSE closes, so we are left gapping up the following today...(I need to be more trusting!). Too unpredictable to trade imho.
Sign In
Follow the stocks
